Konstantinos Efthymakis1, Mariaelena Serio1, Angelo Milano1, Francesco Laterza1, Antonella Bonitatibus1, Marta Di Nicola2, Matteo Neri3. 1. Department of Medicine and Ageing Sciences and Center for Excellence On Ageing and Translational Medicine (CeSI-MeT), "G. D'Annunzio" University and Foundation, Chieti, Italy. 2. Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University and Foundation, Chieti, Italy. 3. Department of Medicine and Ageing Sciences and Center for Excellence On Ageing and Translational Medicine (CeSI-MeT), "G. D'Annunzio" University and Foundation, Chieti, Italy. mneri@unich.it.
Abstract
BACKGROUND: Current adult celiac disease diagnosis requires histological confirmation. However, pediatric guidelines have proposed biopsy-sparing algorithms. AIMS: To explore the applicability of the ESPGHAN criteria and assess the accuracy of serology in predicting disease in adults. METHODS: We evaluated 234 consecutive adults showing elevated anti-tTG titers, EMA-positivity, and genetic susceptibility. Patients underwent upper endoscopy with duodenal biopsy. We determined optimal anti-tTG cutoff levels using ROC curves. RESULTS: Mean anti-tTG levels were 71.1 ± 66.5 U/ml; mean normalized levels were 14.8 ± 14.1 × ULN (mean ± SD). Partial/total villous atrophy was present in 36%/55% of cases, respectively. Anti-tTG levels correlated with histology (r s = 0.397, p < 0.001). AUC was similar before and after normalization (0.803 vs 0.807). Applying the ESPGHAN criterion (≥10 × ULN), we calculated a 97.66% PPV. ROC curve analysis showed an optimal cutoff of ≥16 × ULN, with a PPV of 98.86%. Eleven different assays were used for anti-tTG titer determination: Two were prevalent, labeled A (n = 141) and B (n = 59). They performed differently regarding disease prediction (AUC = 0.689 vs 0.925, p < 0.01), showing distinct optimal cutoff values (14.3 × ULN vs 3.7 × ULN), even after standardization (-0.14 vs -1.2). CONCLUSION: In adult symptomatic patients showing EMA-positivity and genetic susceptibility, anti-tTG titers correlated with histology. ESPGHAN criteria performed similarly to previous studies. However, a calculated 16 × ULN cutoff showed an improved PPV. Among prevalent assays, PPV peaked differently both after normalization and standardization, indicating intrinsic differences in performance, thus preventing uniform prediction of disease in a real-life setting. Assay-specific optimal cutoffs seem possible, but would complicate diagnostic criteria. However, biopsy-sparing strategies in adults could prove useful in challenging patients.
BACKGROUND: Current adult celiac disease diagnosis requires histological confirmation. However, pediatric guidelines have proposed biopsy-sparing algorithms. AIMS: To explore the applicability of the ESPGHAN criteria and assess the accuracy of serology in predicting disease in adults. METHODS: We evaluated 234 consecutive adults showing elevated anti-tTG titers, EMA-positivity, and genetic susceptibility. Patients underwent upper endoscopy with duodenal biopsy. We determined optimal anti-tTG cutoff levels using ROC curves. RESULTS: Mean anti-tTG levels were 71.1 ± 66.5 U/ml; mean normalized levels were 14.8 ± 14.1 × ULN (mean ± SD). Partial/total villous atrophy was present in 36%/55% of cases, respectively. Anti-tTG levels correlated with histology (r s = 0.397, p < 0.001). AUC was similar before and after normalization (0.803 vs 0.807). Applying the ESPGHAN criterion (≥10 × ULN), we calculated a 97.66% PPV. ROC curve analysis showed an optimal cutoff of ≥16 × ULN, with a PPV of 98.86%. Eleven different assays were used for anti-tTG titer determination: Two were prevalent, labeled A (n = 141) and B (n = 59). They performed differently regarding disease prediction (AUC = 0.689 vs 0.925, p < 0.01), showing distinct optimal cutoff values (14.3 × ULN vs 3.7 × ULN), even after standardization (-0.14 vs -1.2). CONCLUSION: In adult symptomatic patients showing EMA-positivity and genetic susceptibility, anti-tTG titers correlated with histology. ESPGHAN criteria performed similarly to previous studies. However, a calculated 16 × ULN cutoff showed an improved PPV. Among prevalent assays, PPV peaked differently both after normalization and standardization, indicating intrinsic differences in performance, thus preventing uniform prediction of disease in a real-life setting. Assay-specific optimal cutoffs seem possible, but would complicate diagnostic criteria. However, biopsy-sparing strategies in adults could prove useful in challenging patients.
Authors: Marco Di Tola; Mariacatia Marino; Simone Goetze; Rossella Casale; Sara Di Nardi; Raffaele Borghini; Giuseppe Donato; Antonio Tiberti; Antonio Picarelli Journal: J Gastroenterol Date: 2016-02-29 Impact factor: 7.527
Authors: R Tortora; N Imperatore; P Capone; G D De Palma; G De Stefano; N Gerbino; N Caporaso; A Rispo Journal: Aliment Pharmacol Ther Date: 2014-09-28 Impact factor: 8.171
Authors: Carina Lagerqvist; Ingrid Dahlbom; Tony Hansson; Erik Jidell; Per Juto; Per Olcén; Hans Stenlund; Olle Hernell; Anneli Ivarsson Journal: J Pediatr Gastroenterol Nutr Date: 2008-10 Impact factor: 2.839
Authors: Santiago Vivas; Jose M Ruiz de Morales; Marisa Fernandez; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Santiago Gutierrez Journal: Am J Gastroenterol Date: 2008-08-12 Impact factor: 10.864
Authors: Ingrid Dahlbom; Ilma R Korponay-Szabó; Judit B Kovács; Zsuzsanna Szalai; Markku Mäki; Tony Hansson Journal: J Pediatr Gastroenterol Nutr Date: 2010-02 Impact factor: 2.839
Authors: Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo Journal: World J Gastroenterol Date: 2009-10-14 Impact factor: 5.742
Authors: Matthew R Donaldson; Linda S Book; Kristin M Leiferman; John J Zone; Susan L Neuhausen Journal: J Clin Gastroenterol Date: 2008-03 Impact factor: 3.062
Authors: Richard David Johnston; Ying Jenny Chan; Tayyib Mubashar; Joseph Robert Bailey; Siba Prosad Paul Journal: Frontline Gastroenterol Date: 2020-10-06
Authors: Hugo A Penny; Suneil A Raju; Michelle S Lau; Lauren Js Marks; Elisabeth Mr Baggus; Julio C Bai; Gabrio Bassotti; Hetty J Bontkes; Antonio Carroccio; Mihai Danciu; Mohammad H Derakhshan; Arzu Ensari; Azita Ganji; Peter H R Green; Matt W Johnson; Sauid Ishaq; Benjamin Lebwohl; Adam Levene; Roxana Maxim; Hamid Mohaghegh Shalmani; Mohammad Rostami-Nejad; David Rowlands; Irene A Spiridon; Amitabh Srivastava; Umberto Volta; Vincenzo Villanacci; Graeme Wild; Simon S Cross; Kamran Rostami; David S Sanders Journal: Gut Date: 2020-11-02 Impact factor: 23.059
Authors: Giuseppe Losurdo; Milena Di Leo; Edoardo Santamato; Monica Arena; Maria Rendina; Carmelo Luigiano; Enzo Ierardi; Alfredo Di Leo Journal: World J Gastroenterol Date: 2021-11-14 Impact factor: 5.742